| NCT03360747 |
Phase 2 Study of AKCEA-ANGPTL3-LRX (ISIS 703802) in Patients With Familial Chylomicronemia Syndrome (FCS) |
https://ClinicalTrials.gov/show/NCT03360747 |
Completed |
Akcea Therapeutics |
2018-09-04 |
| NCT03337308 |
A Study Evaluating the Safety and Efficacy of Bempedoic Acid Plus Ezetimibe Fixed-Dose Combination Compared to Bempedoic Acid, Ezetimibe, and Placebo in Patients Treated With Maximally Tolerated Statin Therapy |
https://ClinicalTrials.gov/show/NCT03337308 |
Completed |
Esperion Therapeutics |
2018-06-18 |
| NCT03330548 |
Pilot Study on the Effects of a Plant-Strong Diet on Cardiovascular Risk Factors |
https://ClinicalTrials.gov/show/NCT03330548 |
Recruiting |
Phoenix VA Health Care System |
2021-05-31 |
| NCT03079648 |
Efficacy and Safety of Angelica Gigas N. Extract on Improvement of Blood Triglyceride |
https://ClinicalTrials.gov/show/NCT03079648 |
Completed |
Chonbuk National University Hospital |
2018-04-06 |
| NCT03070782 |
Phase 2 Study of ISIS 681257 (AKCEA-APO(a)-LRx) in Patients With Hyperlipoproteinemia(a) and Cardiovascular Disease |
https://ClinicalTrials.gov/show/NCT03070782 |
Completed |
Akcea Therapeutics |
2018-07-18 |
| NCT03067688 |
Clinical Trial of Temisartan/Amlodipine & Rosuvastatin in Subjects With Hypertension and Hyperlipidemia |
https://ClinicalTrials.gov/show/NCT03067688 |
Completed |
Yuhan Corporation |
2018-03-27 |
| NCT02991534 |
Cardiovascular Risk Screening and Risk Reduction in Women Vets |
https://ClinicalTrials.gov/show/NCT02991534 |
Recruiting |
VA Office of Research and Development |
2020-08-31 |
| NCT02991118 |
Evaluation of Long-Term Efficacy of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia at High Cardiovascular Risk |
https://ClinicalTrials.gov/show/NCT02991118 |
Completed |
Esperion Therapeutics |
2018-08-22 |
| NCT02959762 |
Vitamin K to Slow Progression of Dyslipidemia and Diabetes Risk (Vita-K ‘n’ Kids Study II) |
https://ClinicalTrials.gov/show/NCT02959762 |
Active, not recruiting |
Augusta University |
2020-12-01 |
| NCT02942602 |
Effect of Lipid Modifying Drugs on HDL Function in Patients With Hyperlipidemia |
https://ClinicalTrials.gov/show/NCT02942602 |
Completed |
Yonsei University |
2016-05-23 |
| NCT02899455 |
Clinical Efficacy and Safety Evaluation of Co-administered HGP0904, HGP0608 and HGP0816 in Patients With Hypertension and Dyslipidemia |
https://ClinicalTrials.gov/show/NCT02899455 |
Completed |
Hanmi Pharmaceutical Company Limited |
2016-06-30 |
| NCT02842359 |
Evaluation of the Fixed-dose Combination of Irbesartan/Atorvastatin in Type 2 Diabetic Patients Diagnosed With Hyperlipidemia and Hypertension |
https://ClinicalTrials.gov/show/NCT02842359 |
Completed |
Sanofi |
2018-04-19 |
| NCT02824432 |
Exploratory Study of the Effect of Omega-3-acid Ethyl Esters (TAK-085) on Vascular Endothelial Function in Patients With Hyperlipidemia by Flow Mediated Dilation |
https://ClinicalTrials.gov/show/NCT02824432 |
Completed |
Takeda |
2017-08-19 |
| NCT02767531 |
Orlistat for the Treatment of Type I Hyperlipoproteinemia |
https://ClinicalTrials.gov/show/NCT02767531 |
Active, not recruiting |
University of Texas Southwestern Medical Center |
2018-05-31 |
| NCT02742545 |
Impact of MayoExpertAdvisor on Provider Adherence |
https://ClinicalTrials.gov/show/NCT02742545 |
Completed |
Mayo Clinic |
2016-11-30 |
| NCT02729025 |
Effects of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition on Arterial Wall Inflammation in Patients With Elevated Lipoprotein(a) (Lp(a)) |
https://ClinicalTrials.gov/show/NCT02729025 |
Completed |
Amgen |
2018-04-05 |
| NCT02719028 |
Trial of Antroquinonol in Patients With Hypercholesterolemia and Hyperlipidemia |
https://ClinicalTrials.gov/show/NCT02719028 |
Completed |
Golden Biotechnology Corporation |
2018-09-27 |
| NCT02668016 |
Self-Assessment Method for Statin Side-effects Or Nocebo |
https://ClinicalTrials.gov/show/NCT02668016 |
Active, not recruiting |
Imperial College London |
2020-02-29 |
| NCT02666664 |
Evaluation of Long-Term Safety and Tolerability of ETC-1002 in High-Risk Patients With Hyperlipidemia and High CV Risk (CLEAR Harmony) |
https://ClinicalTrials.gov/show/NCT02666664 |
Completed |
Esperion Therapeutics |
2018-02-21 |
| NCT02662569 |
Safety and Efficacy of Evolocumab in Combination With Statin Therapy in Adults With Diabetes and Hyperlipidemia or Mixed Dyslipidemia |
https://ClinicalTrials.gov/show/NCT02662569 |
Completed |
Amgen |
2017-12-06 |
| NCT02658175 |
The Approach Open Label Study: A Study of Volanesorsen (Formerly IONIS-APOCIIIRx) in Patients With Familial Chylomicronemia Syndrome |
https://ClinicalTrials.gov/show/NCT02658175 |
Active, not recruiting |
Ionis Pharmaceuticals, Inc. |
2020-06-30 |
| NCT02593032 |
Effects of Use of a Connected Pillbox On Medication Adherence |
https://ClinicalTrials.gov/show/NCT02593032 |
Completed |
University of Pennsylvania |
2017-04-30 |
| NCT02582424 |
Safety and Efficacy of PDL-0101 in Patients With Hyperlipidemias: a Pilot Study. |
https://ClinicalTrials.gov/show/NCT02582424 |
Completed |
Primus Pharmaceuticals |
2013-08-31 |
| NCT02512276 |
Tele-Pharmacy Intervention to Improve Treatment Adherence |
https://ClinicalTrials.gov/show/NCT02512276 |
Completed |
Brigham and Women’s Hospital |
2017-08-31 |
| NCT02458287 |
Efficacy, Safety, Tolerability And Actual Use Study Of Bococizumab And An Autoinjector (Pre-Filled Pen) In Subjects With Hyperlipidemia Or Dyslipidemia |
https://ClinicalTrials.gov/show/NCT02458287 |
Completed |
Pfizer |
2016-02-29 |
| NCT02418637 |
Pilot Study Testing Feasibility of Health Screening at Farm Site |
https://ClinicalTrials.gov/show/NCT02418637 |
Completed |
Mayo Clinic |
2016-09-30 |
| NCT02295293 |
The Effects of Rhus Coriaria L. on Serum Lipid Levels of Patients With Hyperlipidemia |
https://ClinicalTrials.gov/show/NCT02295293 |
Completed |
Shiraz University of Medical Sciences |
2015-04-30 |
| NCT02280590 |
Comparison of the Efficacy and Safety of Cresnon® and Crestor® in Patients With Hyperlipidemia |
https://ClinicalTrials.gov/show/NCT02280590 |
Completed |
Dong-A ST Co., Ltd. |
2015-06-30 |
| NCT02215408 |
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention |
https://ClinicalTrials.gov/show/NCT02215408 |
Completed |
University of Iowa |
2017-06-30 |
| NCT02189837 |
Effects on Lipoprotein Metabolism From PCSK9 Inhibition Utilizing a Monoclonal Antibody |
https://ClinicalTrials.gov/show/NCT02189837 |
Completed |
Amgen |
2015-02-13 |
| NCT02135029 |
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects Who Are Intolerant to Statins |
https://ClinicalTrials.gov/show/NCT02135029 |
Completed |
Pfizer |
2015-11-30 |
| NCT02130505 |
Inflammatory Aspects of Glucose in Hyperlipidemia and Diabetes |
https://ClinicalTrials.gov/show/NCT02130505 |
Completed |
Sint Franciscus Gasthuis |
2008-06-30 |
| NCT02100514 |
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events |
https://ClinicalTrials.gov/show/NCT02100514 |
Completed |
Pfizer |
2016-07-15 |
| NCT02098278 |
Pilot Study To Assess CAT-2003 in Patients With Chylomicronemia |
https://ClinicalTrials.gov/show/NCT02098278 |
Completed |
Catabasis Pharmaceuticals |
2015-04-30 |
| NCT01317524 |
The Effects of Homogenized and Unhomogenized Milk on Postprandial Metabolism in Healthy Overweight Men |
https://ClinicalTrials.gov/show/NCT01317524 |
Completed |
Maastricht University Medical Center |
2011-06-30 |
| NCT01308710 |
The Effects of a Mediterranean Diet in Pediatric Hyperlipidemia |
https://ClinicalTrials.gov/show/NCT01308710 |
Completed |
University of California, San Francisco |
2011-07-31 |
| NCT01291641 |
Effect of Probucol and/or Cilostazol on Mean IMT in Patients With Coronary Heart dIsease |
https://ClinicalTrials.gov/show/NCT01291641 |
Completed |
Seoul National University Hospital |
2016-12-31 |
| NCT01279590 |
Study of the Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients Previously Intolerant to Statins Due to Statin-associated Myalgia (SAM) |
https://ClinicalTrials.gov/show/NCT01279590 |
Completed |
Furiex Pharmaceuticals, Inc |
2011-11-30 |
| NCT02056847 |
to Evaluate the Safety and Efficacy of Pitavastatin in Patients With IFG and Hyperlipidemia |
https://ClinicalTrials.gov/show/NCT02056847 |
Completed |
JW Pharmaceutical |
2017-05-31 |
| NCT02029989 |
Point-of-Care Testing (POCT) Detection and Management of Metabolic Syndrome in Patients With Mental Illness |
https://ClinicalTrials.gov/show/NCT02029989 |
Completed |
University of Minnesota |
2012-02-29 |
| NCT02008084 |
A Pilot Study to Evaluate the Lipid Effects of TRIA-662 |
https://ClinicalTrials.gov/show/NCT02008084 |
Completed |
Cortria Corporation |
2015-10-31 |
| NCT01968967 |
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events |
https://ClinicalTrials.gov/show/NCT01968967 |
Completed |
Pfizer |
2016-07-05 |
| NCT01968954 |
Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events |
https://ClinicalTrials.gov/show/NCT01968954 |
Completed |
Pfizer |
2016-04-30 |
| NCT01953328 |
Study of Low-Density Lipoprotein Cholesterol (LDL-C) Reduction Using Evolocumab (AMG 145) in Japanese Patients With Advanced Cardiovascular Risk |
https://ClinicalTrials.gov/show/NCT01953328 |
Completed |
Amgen |
2014-06-30 |
| NCT01918332 |
Efficacy and Safety of Valsartan 160mg and Rosuvastatin 20mg in Patients With Hypertension and Hyperlipidemia |
https://ClinicalTrials.gov/show/NCT01918332 |
Completed |
LG Life Sciences |
2013-03-31 |
| NCT01914432 |
Efficacy and Safety Study of YH16410 Versus Rosuvastatin and Telmisartan Monotherapies in Patients With Hypertension and Hyperlipidemia |
https://ClinicalTrials.gov/show/NCT01914432 |
Completed |
Yuhan Corporation |
2014-06-30 |
| NCT01912560 |
Pilot Study To Assess CAT-2003 in Patients With Hyperlipidemia |
https://ClinicalTrials.gov/show/NCT01912560 |
Completed |
Catabasis Pharmaceuticals |
2013-12-31 |
| NCT01884246 |
Improving Heart Health in Appalachia |
https://ClinicalTrials.gov/show/NCT01884246 |
Completed |
University of Kentucky |
2016-12-31 |
| NCT01878227 |
Comparison of Coenzyme A and Fenofibrate for Safety and Efficacy On Patients With Hyperlipidemia |
https://ClinicalTrials.gov/show/NCT01878227 |
Completed |
Zhejiang University |
2011-05-31 |
| NCT01865370 |
Efficacy and Safety of Kochujang Pills on Blood Lipids Profiles in Hyperlipidemia Subjects |
https://ClinicalTrials.gov/show/NCT01865370 |
Completed |
Chonbuk National University Hospital |
2012-02-29 |
| NCT01854918 |
Open-label Extension Study of Evolocumab (AMG 145) in Adults With Hyperlipidemia and Mixed Dyslipidemia |
https://ClinicalTrials.gov/show/NCT01854918 |
Completed |
Amgen |
2018-05-31 |
| NCT01845428 |
Lipid Lowering Agents to Limit Lipid Oxidation and Activation of Clotting System in Nephrotic Syndrome |
https://ClinicalTrials.gov/show/NCT01845428 |
Completed |
University of North Carolina, Chapel Hill |
2017-01-31 |
| NCT01811082 |
Comparison of Coenzyme A and Pantethine Capsule for Safety and Efficacy On Patients With Hyperlipidemia |
https://ClinicalTrials.gov/show/NCT01811082 |
Completed |
Zhejiang University |
2011-05-31 |
| NCT01680211 |
Safety and Efficacy Study of Herbal Supplements in Prediabetic and Mild to Moderate Hyperlipidemic Patients |
https://ClinicalTrials.gov/show/NCT01680211 |
Completed |
Olive Lifesciences Pvt Ltd |
2012-06-30 |
| NCT01675154 |
Phase 2 Study of Orlistat and SLx-4090 for the Treatment of Type 1 Hyperlipoproteinemia |
https://ClinicalTrials.gov/show/NCT01675154 |
Active, not recruiting |
University of Texas Southwestern Medical Center |
2020-07-31 |
| NCT01562080 |
Combined Effects of Bioactive Compounds in Lipid Profile |
https://ClinicalTrials.gov/show/NCT01562080 |
Completed |
Rottapharm Spain |
2012-06-30 |
| NCT01541943 |
Efficacy and Safety of HL-040XC in Essential Hypertension and Hyperlipidemia |
https://ClinicalTrials.gov/show/NCT01541943 |
Completed |
HanAll BioPharma Co., Ltd. |
2014-11-30 |
| NCT01524289 |
Study to Assess the Tolerability and Efficacy of Anacetrapib (MK-0859) Co-Administered With Statin in Participants With Heterozygous Familial Hypercholesterolemia (MK-0859-020) |
https://ClinicalTrials.gov/show/NCT01524289 |
Completed |
Merck Sharp & Dohme Corp. |
2014-02-12 |
| NCT01442987 |
Efficacy and Safety of Irbesartan and Atorvastatin in Hypertension and Hyperlipidemia |
https://ClinicalTrials.gov/show/NCT01442987 |
Completed |
Hanmi Pharmaceutical Company Limited |
2013-04-30 |
| NCT01414803 |
Tolerability and Efficacy of Rosuvastatin - Fenofibrate Combine Therapy in Korean Patients With Combined Hyperlipidemia |
https://ClinicalTrials.gov/show/NCT01414803 |
Completed |
Yonsei University |
2011-04-30 |
| NCT01402102 |
A Human Trial to Evaluate the Efficacy and Safety of Aged Garlic Powder on Improvement of Blood Lipids in Subjects With Hyperlipidemia |
https://ClinicalTrials.gov/show/NCT01402102 |
Completed |
Chonbuk National University Hospital |
2011-03-31 |
| NCT01388816 |
A Safety and Efficacy Study of DRL-17822, a Cholesteryl Ester Transfer Protein (CETP) Inhibitor, in Patients With Abnormal Cholesterol Levels |
https://ClinicalTrials.gov/show/NCT01388816 |
Completed |
Dr. Reddy’s Laboratories Limited |
2012-05-31 |
| NCT01360567 |
The Effect of Green Tea Extract on Type 2 Diabetes With Hyperlipidemia |
https://ClinicalTrials.gov/show/NCT01360567 |
Completed |
Taipei City Hospital |
2012-11-30 |
| NCT01349010 |
Efficacy and Safety of Imported Probucol to Treat Hyperlipidemia |
https://ClinicalTrials.gov/show/NCT01349010 |
Completed |
Otsuka Beijing Research Institute |
2012-07-31 |
| NCT01332747 |
Clinical Study to Evaluate Antihyperlipidemic Effect of a Classical Unani Antiobesity Formulation |
https://ClinicalTrials.gov/show/NCT01332747 |
Completed |
Jamia Hamdard University |
2011-05-31 |
| NCT01327014 |
Efficacy and Safety Study of Lipid-Lowering Effects of XueZhiKang (XZK) in Patients With Hyperlipidemia |
https://ClinicalTrials.gov/show/NCT01327014 |
Completed |
Beijing Peking University WBL Biotech Co., Ltd. |
2012-12-31 |
| NCT04209244 |
Effect of Fish Oil on Hyperlipidemia and Toxicities in Children and Young Adults With Acute Lymphoblastic Leukemia |
https://ClinicalTrials.gov/show/NCT04209244 |
Recruiting |
Rigshospitalet, Denmark |
2023-07-31 |
| NCT04069715 |
The Effect of Farlong® NotoGinseng™ (Farlong® Ginseng Plu®) on Cholesterol and Blood Pressure |
https://ClinicalTrials.gov/show/NCT04069715 |
Enrolling by invitation |
LongStar HealthPro, Inc. DBA Farlong Pharmaceutical |
2020-02-28 |
| NCT04036773 |
Food Pharmacy at Oregon Health & Science University (OHSU) Knight Cardiovascular Institute (KCVI) |
https://ClinicalTrials.gov/show/NCT04036773 |
Recruiting |
Oregon Health and Science University |
2020-07-15 |
| NCT03944109 |
The Safety, Tolerability and Efficacy of Multiple Subcutaneous Injections of SHR-1209 in Subjects With Hyperlipidemia |
https://ClinicalTrials.gov/show/NCT03944109 |
Recruiting |
Jiangsu HengRui Medicine Co., Ltd. |
2020-06-30 |
| NCT03857256 |
Compare the Efficacy and Safety of Beta-Glucan as Add-On to Statin in Subjects With Hyperlipidemia. |
https://ClinicalTrials.gov/show/NCT03857256 |
Recruiting |
Montreal Heart Institute |
2020-11-01 |
| NCT03680027 |
Effects Of Walnut-Enriched Diet On Blood Lipids And Glucose Profiles In Hyperlipidemic Subjects |
https://ClinicalTrials.gov/show/NCT03680027 |
Completed |
Eastern Mediterranean University |
2015-08-27 |
| NCT03639480 |
Study to Evaluate the Safety and Efficacy of CJ-30061 in Hypertensive Patients With Hyperlipidemia |
https://ClinicalTrials.gov/show/NCT03639480 |
Enrolling by invitation |
CJ HealthCare Corporation |
2018-10-31 |
| NCT03607383 |
Red Rice Yeast in Low-density Lipoprotein (LDL) Lowering: an Efficacy Study |
https://ClinicalTrials.gov/show/NCT03607383 |
Recruiting |
Saint-Joseph University |
2020-04-30 |
| NCT03566316 |
Efficacy/Safety of Telmisartan/Amlodipine/Rosuvastatin in Hypertensive Patients With Hyperlipidemia |
https://ClinicalTrials.gov/show/NCT03566316 |
Completed |
IlDong Pharmaceutical Co Ltd |
2017-06-16 |
| NCT03550287 |
Evaluation of the Effect of a Shiitake Extract on Lipid Profile in Subjects With Moderate Hyperlipidemia |
https://ClinicalTrials.gov/show/NCT03550287 |
Completed |
Instituto de Investigación Hospital Universitario La Paz |
2017-06-30 |
| NCT03536598 |
Study to Evaluate the Safety and Efficacy of CJ-30060 in Hypertensive Patients With Hyperlipidemia |
https://ClinicalTrials.gov/show/NCT03536598 |
Completed |
CJ HealthCare Corporation |
2017-09-04 |
| NCT03434613 |
A Randomized, Prospective, Open Label, Active Control, Phase IV Study to Evaluate the Effects of Statin Monotherapy or Statin / Ezetimibe Combination Therapy on Hepatic Steatosis in Patients With Hyperlipidemia and Nonalcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT03434613 |
Completed |
Yonsei University |
2019-09-11 |
| NCT01267227 |
Effect of Pterostilbene on Cholesterol, Blood Pressure and Oxidative Stress |
https://ClinicalTrials.gov/show/NCT01267227 |
Completed |
University of Mississippi Medical Center |
2012-02-29 |
| NCT01256476 |
Prevail-Us: A Study Of Pitavastatin 4 mg Vs. Pravastatin 40 mg In Patients With Primary Hyperlipidemia Or Mixed Dyslipidemia |
https://ClinicalTrials.gov/show/NCT01256476 |
Completed |
Kowa Research Institute, Inc. |
2011-06-30 |
| NCT01236430 |
A Study to Determine the Bioequivalence of SCH 900068 Compared to Marketed Products (Protocol No. P07551) |
https://ClinicalTrials.gov/show/NCT01236430 |
Completed |
Merck Sharp & Dohme Corp. |
2011-11-30 |
| NCT01212159 |
Telephone Based Management of Hyperlipidemia |
https://ClinicalTrials.gov/show/NCT01212159 |
Completed |
Temple University |
2015-07-31 |
| NCT01152073 |
A Study Of Nutraceutical Drinks For Cholesterol (Evaluating Effectiveness and Tolerability) |
https://ClinicalTrials.gov/show/NCT01152073 |
Completed |
Healthy Drink Discoveries, Inc. |
2010-09-30 |
| NCT01146522 |
Safety, Tolerability,Pharmacokinetics(PK)and Pharmacodynamics(PD)Assessment of LCQ908 in Patients With Severe Hypertriglyceridemia |
https://ClinicalTrials.gov/show/NCT01146522 |
Completed |
Novartis |
2011-10-31 |
| NCT01142908 |
Cardiovascular Intervention Improvement Telemedicine Study |
https://ClinicalTrials.gov/show/NCT01142908 |
Completed |
VA Office of Research and Development |
2015-04-30 |
| NCT01133522 |
Ascending Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Evolocumab (AMG 145) in Adults With Hyperlipidemia on Stable Doses of a Statin |
https://ClinicalTrials.gov/show/NCT01133522 |
Completed |
Amgen |
2011-09-14 |
| NCT01099176 |
Effects of Hypolipemic Treatment on Adipokines |
https://ClinicalTrials.gov/show/NCT01099176 |
Completed |
Medical University of Silesia |
2009-05-31 |
| NCT01089231 |
Effects of Omega-3 Fatty Acids on the Human Gene Expression |
https://ClinicalTrials.gov/show/NCT01089231 |
Completed |
Gottfried Wilhelm Leibniz Universität Hannover |
2010-07-31 |
| NCT01057654 |
A Study Comparing the Mechanisms of Action of Lifibrol and Pravastatin |
https://ClinicalTrials.gov/show/NCT01057654 |
Completed |
University Hospital, Bonn |
1996-04-30 |
| NCT01023607 |
Evaluation of Statin-induced Lipid-rich Plaque Progression by Optical Coherence Tomography (OCT) Combined With Intravascular Ultrasound (IVUS) |
https://ClinicalTrials.gov/show/NCT01023607 |
Completed |
Harbin Medical University |
2013-08-31 |
| NCT00974272 |
Effects of Exenatide on Postprandial Hyperlipidemia and Inflammation |
https://ClinicalTrials.gov/show/NCT00974272 |
Completed |
Carl T. Hayden VA Medical Center |
2008-11-30 |
| NCT00973115 |
Efficacy and Safety of Morning Versus Evening Intake of Simvast Controlled Release (CR) Tablet in Patients With Hyperlipidemia |
https://ClinicalTrials.gov/show/NCT00973115 |
Completed |
Hanmi Pharmaceutical Company Limited |
2009-08-31 |
| NCT00941603 |
Phase 2 Dose-Ranging Efficacy and Safety Trial of SCH 900271 in Participants With Primary Hypercholesterolemia or Mixed Hyperlipidemia (P05675) |
https://ClinicalTrials.gov/show/NCT00941603 |
Completed |
Merck Sharp & Dohme Corp. |
2010-02-22 |
| NCT00917878 |
Postprandial Effects of Milk and Milk Constituents |
https://ClinicalTrials.gov/show/NCT00917878 |
Completed |
Maastricht University Medical Center |
2009-07-31 |
| NCT00897975 |
Red Yeast Rice and Phytosterols In Statin Intolerance |
https://ClinicalTrials.gov/show/NCT00897975 |
Completed |
Chestnut Hill Health System |
2010-11-30 |
| NCT00887653 |
Changes in Lipids and Safety of Raltegravir in HIV+ Patients With Hyperlipidemia While on Current Standard Therapy |
https://ClinicalTrials.gov/show/NCT00887653 |
Completed |
The Miriam Hospital |
2012-06-30 |
| NCT02833844 |
Safety, Tolerability & Efficacy on LDL-C of Evolocumab in Subjects With HIV & Hyperlipidemia/Mixed Dyslipidemia |
https://ClinicalTrials.gov/show/NCT02833844 |
Completed |
Amgen |
2019-07-09 |
| NCT00813527 |
Effect of Lapaquistat Acetate Combined With Fenofibrate on Blood Cholesterol Levels |
https://ClinicalTrials.gov/show/NCT00813527 |
Completed |
Takeda |
2007-01-31 |
| NCT00810979 |
Comparison of SLx-4090 Combined With Statin Therapy Versus Statin Alone in Reducing LDL-C in Patients With Hyperlipidemia |
https://ClinicalTrials.gov/show/NCT00810979 |
Completed |
Kadmon Corporation, LLC |
2009-09-30 |
| NCT01645046 |
The Effects of Coenzyme A on Serum Lipids in Patients With Hyperlipidemia |
https://ClinicalTrials.gov/show/NCT01645046 |
Completed |
Zhejiang University |
2009-06-30 |
| NCT02100839 |
Safety Study of AEM-28 to Treat Refractory Hypercholesterolemia |
https://ClinicalTrials.gov/show/NCT02100839 |
Completed |
LipimetiX Development, LLC |
2014-11-30 |
| NCT03961763 |
Effect of n-3 Fatty Acid Supplementation in Hyperlipidemic Patients Taking Statins |
https://ClinicalTrials.gov/show/NCT03961763 |
Completed |
University of Chester |
2017-11-01 |
| NCT03828188 |
Efficacy and Safety of Red Ginseng Concentrated Powder on Improvement of Blood Triglyceride Level |
https://ClinicalTrials.gov/show/NCT03828188 |
Completed |
Chonbuk National University Hospital |
2018-05-11 |
| NCT00947635 |
Cholesterol and Fatty Acid Synthesis in Islet and Liver Transplant Patients and Effect of Dietary Intervention |
https://ClinicalTrials.gov/show/NCT00947635 |
Completed |
University of Alberta |
2009-06-30 |
| NCT00754039 |
Study to Compare Welchol and TriCor to TriCor Alone in Patients With High Cholesterol |
https://ClinicalTrials.gov/show/NCT00754039 |
Completed |
Daiichi Sankyo, Inc. |
2003-09-30 |
| NCT00713167 |
The Efficacy of Red Grape Seed Extract on Lipid Profile and Oxidized Low-Density Lipoprotein (OX-LDL) |
https://ClinicalTrials.gov/show/NCT00713167 |
Completed |
Shahid Beheshti University of Medical Sciences |
2008-12-31 |
| NCT00701883 |
Safety and Benefit of MBX-8025 With and Without Commonly Used Statins in Moderately Overweight Patients With High Cholesterol |
https://ClinicalTrials.gov/show/NCT00701883 |
Completed |
CymaBay Therapeutics, Inc. |
2008-08-31 |
| NCT00694109 |
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia |
https://ClinicalTrials.gov/show/NCT00694109 |
Completed |
Kastle Therapeutics, LLC |
2014-09-30 |
| NCT00688896 |
Efficacy and Safety Study of JTT-705 in Combination With Pravastatin 40 mg in Patients With Type II Hyperlipidemia |
https://ClinicalTrials.gov/show/NCT00688896 |
Completed |
Akros Pharma Inc. |
2003-04-30 |
| NCT00686010 |
Efficacy and Safety of JTT-705 300, 600 And 900mg in Comparison With Placebo in Patients With Type II Hyperlipidaemia |
https://ClinicalTrials.gov/show/NCT00686010 |
Completed |
Japan Tobacco Inc. |
2001-01-31 |
| NCT00685737 |
Safety of a Hypolipidemic Agent in Healthy Normal Volunteers |
https://ClinicalTrials.gov/show/NCT00685737 |
Completed |
Pharmena North America |
2008-06-30 |
| NCT00668109 |
Assessment of Efficacy of Vardenafil in Subjects With Erectile Dysfunction and Diabetes, Hypertension or Hyperlipidemia |
https://ClinicalTrials.gov/show/NCT00668109 |
Completed |
Bayer |
2004-06-30 |
| NCT00645424 |
A Study To Evaluate The Safety And Efficacy Of Atorvastatin In Patients With Diabetes And High Cholesterol |
https://ClinicalTrials.gov/show/NCT00645424 |
Completed |
Pfizer |
NA |
| NCT00607373 |
Study to Assess the Safety and Efficacy of ISIS 301012 (Mipomersen) in Homozygous Familial Hypercholesterolemia |
https://ClinicalTrials.gov/show/NCT00607373 |
Completed |
Kastle Therapeutics, LLC |
2009-03-31 |
| NCT01239004 |
Colesevelam Treatment for Impaired Fasting Glucose During Niacin Therapy |
https://ClinicalTrials.gov/show/NCT01239004 |
Completed |
Radiant Research |
2011-08-31 |
| NCT00565292 |
A Study of MK0859 in Patients With Primary Hypercholesterolemia or Mixed Hyperlipidemia (MK-0859-011)(COMPLETED) |
https://ClinicalTrials.gov/show/NCT00565292 |
Completed |
Merck Sharp & Dohme Corp. |
2006-08-31 |
| NCT00552097 |
Effect of Ezetimibe Plus Simvastatin Versus Simvastatin Alone on Atherosclerosis in the Carotid Artery (ENHANCE)(P02578) |
https://ClinicalTrials.gov/show/NCT00552097 |
Completed |
Merck Sharp & Dohme Corp. |
2006-04-25 |
| NCT00536510 |
Effect of MK0524A on Cholesterol Levels (0524A-048) |
https://ClinicalTrials.gov/show/NCT00536510 |
Completed |
Merck Sharp & Dohme Corp. |
2008-03-31 |
| NCT00507520 |
Almond Dose Response Study. |
https://ClinicalTrials.gov/show/NCT00507520 |
Completed |
University of Toronto |
NA |
| NCT00490672 |
Community Based Multiple Risk Factors Intervention Strategy |
https://ClinicalTrials.gov/show/NCT00490672 |
Completed |
Ministry of Health, Malaysia |
2008-12-31 |
| NCT00477594 |
Open Label Extension of ISIS 301012 (Mipomersen) to Treat Familial Hypercholesterolemia |
https://ClinicalTrials.gov/show/NCT00477594 |
Completed |
Kastle Therapeutics, LLC |
2011-03-31 |
| NCT00473655 |
Effect of Rosuvastatin on Triglyceride Levels in Mexican Hypertriglyceridemic Patients |
https://ClinicalTrials.gov/show/NCT00473655 |
Completed |
AstraZeneca |
2009-02-28 |
| NCT00465088 |
An Open-Label Study to Compare the Lipid Effects of Niacin ER and Simvastatin (NS) to Atorvastatin in Subjects With Hyperlipidemia or Mixed Dyslipidemia (SUPREME) |
https://ClinicalTrials.gov/show/NCT00465088 |
Completed |
Abbott |
2008-02-29 |
| NCT00459745 |
A Study to Evaluate Daily Pravastatin, Fenofibrate or Pravafen in the Treatment of Combined Hyperlipidemia |
https://ClinicalTrials.gov/show/NCT00459745 |
Completed |
Shionogi Inc. |
2008-04-30 |
| NCT00457262 |
Effects of Soy Protein on Serum paraoxonase1 Activity and Lipoproteins in Postmenopausal Women |
https://ClinicalTrials.gov/show/NCT00457262 |
Completed |
Iran University of Medical Sciences |
NA |
| NCT00438425 |
Portfolio 5 - Multicentre Dietary Advice on Serum Lipids in Hyperlipidemia |
https://ClinicalTrials.gov/show/NCT00438425 |
Completed |
University of Toronto |
2009-09-30 |
| NCT00405769 |
Lipid Lowering in Patients With Statin Intolerance |
https://ClinicalTrials.gov/show/NCT00405769 |
Completed |
Chestnut Hill Health System |
NA |
| NCT00393419 |
Federal Study of Adherence to Medications in the Elderly (FAME) |
https://ClinicalTrials.gov/show/NCT00393419 |
Completed |
Walter Reed Army Medical Center |
NA |
| NCT00378833 |
Tolerability of MK0524A Versus Niacin Extended-Release (0524A-054) |
https://ClinicalTrials.gov/show/NCT00378833 |
Completed |
Merck Sharp & Dohme Corp. |
2007-03-31 |
| NCT00376584 |
Effect of an Investigational Compound on Tolerability of Extended Release Niacin (0524A-023)(COMPLETED) |
https://ClinicalTrials.gov/show/NCT00376584 |
Completed |
Merck Sharp & Dohme Corp. |
2007-01-31 |
| NCT00362934 |
Comparison of the Combination of Fenofibrate and Simvastatin Versus Atorvastatin |
https://ClinicalTrials.gov/show/NCT00362934 |
Completed |
Solvay Pharmaceuticals |
2008-08-31 |
| NCT00362206 |
Comparison of the Combination of Fenofibrate and Simvastatin Versus Pravastatin |
https://ClinicalTrials.gov/show/NCT00362206 |
Completed |
Solvay Pharmaceuticals |
2008-09-30 |
| NCT00362180 |
Measure Liver Fat Content After ISIS 301012 (Mipomersen) Administration |
https://ClinicalTrials.gov/show/NCT00362180 |
Completed |
Kastle Therapeutics, LLC |
2010-03-31 |
| NCT00360217 |
The Triglyceride Lowering Effect of an Omega-3 Fat (DHA) in Addition to Statin Therapy for Patients With CAD or Diabetes |
https://ClinicalTrials.gov/show/NCT00360217 |
Completed |
Maine Center for Lipids and Cardiovascular Health |
NA |
| NCT00349375 |
Comparison of the Combination of Fenofibrate and 20 mg Simvastatin Versus 40 mg Simvastatin Monotherapy |
https://ClinicalTrials.gov/show/NCT00349375 |
Completed |
Solvay Pharmaceuticals |
2008-09-30 |
| NCT00349284 |
A Controlled-Study of Fenofibrate 145 mg and Ezetimibe 10 mg in Type IIb Dyslipidemic Patients With Features of the Metabolic Syndrome |
https://ClinicalTrials.gov/show/NCT00349284 |
Completed |
Solvay Pharmaceuticals |
NA |
| NCT00345657 |
Efficacy Study of Extended-Release Niacin/Lovastatin Versus Usual Care |
https://ClinicalTrials.gov/show/NCT00345657 |
Completed |
In His Image |
NA |
| NCT00308386 |
DYNAMIC Study: (Diabetes Nurse Case Management And Motivational Interviewing for Change) |
https://ClinicalTrials.gov/show/NCT00308386 |
Completed |
Milton S. Hershey Medical Center |
2011-07-27 |
| NCT00296400 |
Prospective Evaluation of Proteinuria and Renal Function in Non-diabetic Patients With Progressive Renal Disease |
https://ClinicalTrials.gov/show/NCT00296400 |
Completed |
AstraZeneca |
2009-06-30 |
| NCT00289900 |
Lipid Efficacy and Safety in Participants With Mixed Hyperlipidemia (MK-0524B-024) |
https://ClinicalTrials.gov/show/NCT00289900 |
Completed |
Merck Sharp & Dohme Corp. |
2010-08-06 |
| NCT00271817 |
To Evaluate Ezetimibe/Simvastatin and Niacin (Extended Release Tablet) in Patients With Type IIa or Type IIb Hyperlipidemia (0653A-091)(COMPLETED) |
https://ClinicalTrials.gov/show/NCT00271817 |
Completed |
Merck Sharp & Dohme Corp. |
2008-02-29 |
| NCT00269217 |
Lipid Efficacy Study (0524B-022)(COMPLETED) |
https://ClinicalTrials.gov/show/NCT00269217 |
Completed |
Merck Sharp & Dohme Corp. |
2007-01-31 |
| NCT00269204 |
Lipid Efficacy/Tolerability Study (0524A-020) |
https://ClinicalTrials.gov/show/NCT00269204 |
Completed |
Merck Sharp & Dohme Corp. |
2006-12-31 |
| NCT00249938 |
Evaluation of Combination Cholesterol Treatments in Patients With High Cholesterol. |
https://ClinicalTrials.gov/show/NCT00249938 |
Completed |
University of Colorado, Denver |
NA |
| NCT00246402 |
Acipimox to Improve Hyperlipidemia and Insulin Sensitivity Associated With HIV |
https://ClinicalTrials.gov/show/NCT00246402 |
Completed |
National Heart, Lung, and Blood Institute (NHLBI) |
NA |
| NCT00244231 |
Efficacy and Safety Study of Nidadd in the Management of Hyperlipidemia |
https://ClinicalTrials.gov/show/NCT00244231 |
Completed |
Genovate Biotechnology Co., Ltd., |
NA |
| NCT00227500 |
Pravastatin for Hyperlipidaemia in HIV. |
https://ClinicalTrials.gov/show/NCT00227500 |
Completed |
Kirby Institute |
NA |
| NCT00214604 |
Type III Dysbetalipoproteinemia |
https://ClinicalTrials.gov/show/NCT00214604 |
Completed |
AstraZeneca |
2007-02-28 |
| NCT00211705 |
Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese(MEGA Study) |
https://ClinicalTrials.gov/show/NCT00211705 |
Completed |
Mitsukoshi Health and Welfare Foundation |
NA |
| NCT00203476 |
A Prospective, Open Label Comparison of Ezetimibe, Niacin, and Colestipol as Adjunct Therapy in Lipid Reduction |
https://ClinicalTrials.gov/show/NCT00203476 |
Completed |
Tuscaloosa Research & Education Advancement Corporation |
2008-01-31 |
| NCT00195793 |
A 16 Week Comparative Study of Fenofibrate Versus Ezetimibe as Add-on Therapy to Atorvastatin |
https://ClinicalTrials.gov/show/NCT00195793 |
Completed |
Abbott |
NA |
| NCT00189085 |
Effects of Ezetimibe on Postprandial Hyperlipidemia and Endothelial Function |
https://ClinicalTrials.gov/show/NCT00189085 |
Completed |
UMC Utrecht |
NA |
| NCT00184951 |
Pharmacokinetic Study of Rosuvastatin and Lopinavir/Ritonavir in HIV Patients |
https://ClinicalTrials.gov/show/NCT00184951 |
Completed |
Radboud University |
2005-07-31 |
| NCT00174330 |
Comparing Amlodipine/Atorvastatin Co-Administration To Amlodipine Alone In Patients With Hypertension And Dyslipidemia |
https://ClinicalTrials.gov/show/NCT00174330 |
Completed |
Pfizer |
NA |
| NCT00160329 |
Atazanavir or Boosted Atazanavir Substitution for Ritonavir Boosted PI in Patients With Hyperlipidemia |
https://ClinicalTrials.gov/show/NCT00160329 |
Completed |
Stanford University |
2007-04-30 |
| NCT00139061 |
Assess HDL-C Increase And Non-HDL Lowering Effect Of Torcetrapib/Atorvastatin Vs. Fenofibrate |
https://ClinicalTrials.gov/show/NCT00139061 |
Completed |
Pfizer |
NA |
| NCT00134498 |
A Study Comparing The Efficacy & Safety Of Torcetrapib/Atorvastatin And Atorvastatin In Subjects With High Triglycerides |
https://ClinicalTrials.gov/show/NCT00134498 |
Completed |
Pfizer |
NA |
| NCT00117494 |
Rosuvastatin Versus Pravastatin in HIV Patients Treated With Boosted Protease Inhibitors (PI) (ANRS126) |
https://ClinicalTrials.gov/show/NCT00117494 |
Completed |
French National Agency for Research on AIDS and Viral Hepatitis |
2007-03-31 |
| NCT00114855 |
The Effect of Hypocol® on Lipids in Subjects With Mild Hypercholesterolemia and Mildly Elevated Blood Glucose |
https://ClinicalTrials.gov/show/NCT00114855 |
Completed |
Oslo University Hospital |
2005-12-31 |
| NCT00093899 |
A Study to Evaluate an Investigational Drug in Patients With Mixed Hyperlipidemia (0653A-071)(COMPLETED) |
https://ClinicalTrials.gov/show/NCT00093899 |
Completed |
Merck Sharp & Dohme Corp. |
2005-09-30 |
| NCT00092573 |
Study of Ezetimibe and Fenofibrate in Patients With Mixed Hyperlipidemia (0653-036)(COMPLETED) |
https://ClinicalTrials.gov/show/NCT00092573 |
Completed |
Merck Sharp & Dohme Corp. |
2004-11-30 |
| NCT00092560 |
Two Investigational Drugs in Patients With Mixed Hyperlipidemia (0653-036) |
https://ClinicalTrials.gov/show/NCT00092560 |
Completed |
Merck Sharp & Dohme Corp. |
2003-12-31 |
| NCT00552747 |
Effect of Fenofibrate on Endothelial Function and High-density Lipoproteins (HDL)in Patients With Coronary Heart Disease |
https://ClinicalTrials.gov/show/NCT00552747 |
Completed |
National Heart Institute, Mexico |
2010-03-31 |
| NCT00108459 |
Low Carbohydrate Diet Compared to Calorie and Fat Restricted Diet in Patients With Obesity and Type II Diabetes |
https://ClinicalTrials.gov/show/NCT00108459 |
Completed |
VA Office of Research and Development |
NA |
| NCT00006493 |
Rosiglitazone in the Treatment of HIV-Associated Hyperlipidemia |
https://ClinicalTrials.gov/show/NCT00006493 |
Completed |
National Center for Research Resources (NCRR) |
NA |
| NCT00000538 |
Dietary Effects on Lipoproteins and Thrombogenic Activity (DELTA) |
https://ClinicalTrials.gov/show/NCT00000538 |
Completed |
University of North Carolina, Chapel Hill |
1995-05-31 |